|
Oct 16
|
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline
|
|
Oct 10
|
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
|
|
Oct 1
|
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
|
|
Jul 31
|
Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence
|
|
Jul 29
|
Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank
|
|
Jul 25
|
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024
|
|
May 13
|
ACHV: First Quarter Results
|
|
May 10
|
Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results
|
|
May 10
|
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
|
|
May 6
|
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
|
|
Apr 29
|
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
|
|
Apr 25
|
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
|
|
Apr 11
|
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
|
|
Apr 1
|
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript
|
|
Apr 1
|
ACHV: 2023 Results
|
|
Mar 29
|
Q4 2023 Achieve Life Sciences Inc Earnings Call
|
|
Mar 28
|
Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval
|
|
Mar 28
|
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
|
|
Mar 20
|
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
|